WO1995005799A1 - Deodorant composition - Google Patents
Deodorant composition Download PDFInfo
- Publication number
- WO1995005799A1 WO1995005799A1 PCT/EP1994/002745 EP9402745W WO9505799A1 WO 1995005799 A1 WO1995005799 A1 WO 1995005799A1 EP 9402745 W EP9402745 W EP 9402745W WO 9505799 A1 WO9505799 A1 WO 9505799A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- deodorant
- composition
- rco
- acyl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 239000002781 deodorant agent Substances 0.000 title claims abstract description 37
- 125000002252 acyl group Chemical group 0.000 claims abstract description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 8
- 230000000699 topical effect Effects 0.000 claims abstract description 7
- -1 isostearyl Chemical group 0.000 claims description 7
- 239000003205 fragrance Substances 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 239000004411 aluminium Substances 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 3
- 230000001166 anti-perspirative effect Effects 0.000 claims description 3
- 239000003213 antiperspirant Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 150000003754 zirconium Chemical class 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 description 18
- 239000003380 propellant Substances 0.000 description 10
- 239000000443 aerosol Substances 0.000 description 6
- 239000007921 spray Substances 0.000 description 5
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000003974 emollient agent Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 description 1
- 229910002016 Aerosil® 200 Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920004511 Dow Corning® 200 Fluid Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- 239000004110 Zinc silicate Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- WYANSMZYIOPJFV-UHFFFAOYSA-L aluminum;2-aminoacetic acid;zirconium(4+);chloride;hydroxide;hydrate Chemical compound O.[OH-].[Al+3].[Cl-].[Zr+4].NCC(O)=O WYANSMZYIOPJFV-UHFFFAOYSA-L 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000010374 citricidal Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- XZTWHWHGBBCSMX-UHFFFAOYSA-J dimagnesium;phosphonato phosphate Chemical compound [Mg+2].[Mg+2].[O-]P([O-])(=O)OP([O-])([O-])=O XZTWHWHGBBCSMX-UHFFFAOYSA-J 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- ORUIBWPALBXDOA-UHFFFAOYSA-L magnesium fluoride Chemical compound [F-].[F-].[Mg+2] ORUIBWPALBXDOA-UHFFFAOYSA-L 0.000 description 1
- 229910001635 magnesium fluoride Inorganic materials 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 229940105112 magnesium myristate Drugs 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 229940063002 magnesium palmitate Drugs 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- BJZBHTNKDCBDNQ-UHFFFAOYSA-L magnesium;dodecanoate Chemical compound [Mg+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O BJZBHTNKDCBDNQ-UHFFFAOYSA-L 0.000 description 1
- ABSWXCXMXIZDSN-UHFFFAOYSA-L magnesium;hexadecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O ABSWXCXMXIZDSN-UHFFFAOYSA-L 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- DMRBHZWQMKSQGR-UHFFFAOYSA-L magnesium;tetradecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O DMRBHZWQMKSQGR-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- AXLHVTKGDPVANO-UHFFFAOYSA-N methyl 2-amino-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound COC(=O)C(N)CNC(=O)OC(C)(C)C AXLHVTKGDPVANO-UHFFFAOYSA-N 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
- 229940043825 zinc carbonate Drugs 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 229940098697 zinc laurate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- LRXTYHSAJDENHV-UHFFFAOYSA-H zinc phosphate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LRXTYHSAJDENHV-UHFFFAOYSA-H 0.000 description 1
- XSMMCTCMFDWXIX-UHFFFAOYSA-N zinc silicate Chemical compound [Zn+2].[O-][Si]([O-])=O XSMMCTCMFDWXIX-UHFFFAOYSA-N 0.000 description 1
- 235000019352 zinc silicate Nutrition 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- VRGNUPCISFMPEM-ZVGUSBNCSA-L zinc;(2r,3r)-2,3-dihydroxybutanedioate Chemical compound [Zn+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O VRGNUPCISFMPEM-ZVGUSBNCSA-L 0.000 description 1
- LPEBYPDZMWMCLZ-CVBJKYQLSA-L zinc;(z)-octadec-9-enoate Chemical compound [Zn+2].CCCCCCCC\C=C/CCCCCCCC([O-])=O.CCCCCCCC\C=C/CCCCCCCC([O-])=O LPEBYPDZMWMCLZ-CVBJKYQLSA-L 0.000 description 1
- GPYYEEJOMCKTPR-UHFFFAOYSA-L zinc;dodecanoate Chemical compound [Zn+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O GPYYEEJOMCKTPR-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
Definitions
- This invention relates to deodorant compositions suitable for application to the human skin, in particular liquid, solid and aerosol compositions.
- Such compositions may be suitable for use when delivered from a roll-on dispenser, or from a pump action dispenser, or as a stick form, but most preferably from a propellant driven aerosol.
- deodorant and antiperspirant market is dominated with products which are based on aluminium or zirconium salts, which are intended to prevent, or at least to control perspiration at the skin surface, particularly at the underarm, whilst at the same time providing a perceived degree of deodorancy.
- deodorant agents Whilst there are many known deodorant agents available to the skilled man to prepare deodorant compositions, there is still a demand for new deodorant compositions which contain conventional known deodorant agents (which may for example be organic, or based on metal salts) which have improved sensory or skin benefit properties. Such deodorant agents may not only have good efficacy in eliminating odour, but may also provide to the users skin such benefits such as moisturizing and skin elasticity benefits, thereby improving the usage properties of the composition.
- conventional known deodorant agents which may for example be organic, or based on metal salts
- Such deodorant agents may not only have good efficacy in eliminating odour, but may also provide to the users skin such benefits such as moisturizing and skin elasticity benefits, thereby improving the usage properties of the composition.
- acyl lactylate compounds may provide these desir oie properties, including improving skin elasticity as well as providing a degree of deodorancy in deodorant compositions.
- a deodorant composition suitable for topical - .
- RCO represents a C_ ; to C_ . , acyl group; M represents H or a cosmetically suitable counterion having a valency of 1 or 2 ,* a is an integer of from 1 to 4; and b is 1 or 2, in a cosmetically suitable vehicle.
- the cosmetically suitable vehicle may comprise water, volatile silicone, short chain monohydric alcohol, or mixtures thereof.
- the invention provides a deodorant composition for topical application to the human skin, comprising:
- RCO represents a C, to C : , 0 acyl group
- M represents H or a cosmetically suitable counterion having a valency of 1 or 2
- a is an integer of from
- composition from 0.01 to 2% by weight of a fragrance, in a cosmetically acceptable vehicle.
- a fragrance in a cosmetically acceptable vehicle.
- the composition is in the form of a propellant driven aerosol or pump spray formulation it is particularly preferred that the composition contains 35 to 50% of a short chain monohydric alcohol.
- the composition may contain up to 1% by weight, more preferably 0.1-0.4%, of an emollient.
- an emollient is Estol, ex Unichema.
- composition may also preferably contain up to 1.5% by weight of a solubilizer, more preferably 0.3 to 0.7% by weight.
- a solubilizer is Cremaphore RH410, ex BASF.
- the preferred short chain monohydric ethanol for use in the composition is ethanol; the short chain monohydric alcohol can more preferably be present in the composition at a level of 35-50% by weight.
- the fragrance can preferably be present in the composition at a level of 0.7 to 1.7% by weight.
- compositions according to the invention may comprise an additional deodorant active agent, to provide the composition with a deodorant effect over and above any deodorant effect provided by the short chain monohydric alcohol .
- the invention provides a deodorant composition for topical applications to the human skin, comprising:
- RCO represents a C 4 to C 20 acyl group
- M represnets H or a cosmetically suitable counterion having a valency of 1 or 2
- a is an integer of from 1 to 4
- b is 1 or 2;
- a preferred acyl lactylate compound for use in deodorant compositions according to the invention is the iso C 18 variant; that is isostearyl lactylate, though preferred acyl lactylates are those where RCO represents a C 14 -C 20 group.
- M in structure (1) is a counterion, then it is preferably chosen from alkali metal cations, alkaline earth metal cations, ammonium or substituted ammonium having one or more C, to C, alkyl or hydroxy alkyl groups, and may preferably be sodium.
- acyl lactylates are used in form of their free acids; that is to say that M in structure (1) is hydrogen.
- a preferred acyl lactylate is sodium monoisobutyl lactylate.
- acyl lactylates into deodorant compositions has been found to provide beneficial effects, in terms of improved skin condition.
- a build up of effect of acyl lactylates on the skin may be observed after repeated usage.
- Acyl lactylates are able to penetrate the stratum corneum where they are cleaved to release lactic acid.
- Improved elasticity of the epidermis can be one of the benefits of this treatment, along with improved moisture levels in the skin itself.
- Acyl lactylate compounds which are employed in deodorant compositions according to the invention may readily be prepared by conventional techniques known in the art. Many are also commercially available. Preferably the acyl lactylate compounds used in compositions according to the invention are present at a level of 0.001-10%, more preferably 0.01-3% by weight of the composition.
- the deodorant active which may be present in the composition may be any conventional deodorant active .
- the deodorant agent may for example be a soluble, insoluble or sparingly soluble metal salt.
- suitable salts include zinc oxide, zinc carbonate, zinc citrate, zinc laurate, zinc oleate, zinc orthophosphate, zinc silicate, zinc stearate, zinc tartrate, magnesium oxide, magnesium carbonate, magnesium fluoride, magnesium hydroxide, magnesium laurate, magnesium myristate, magnesium oleate, magnesium palmitate, magnesium stearate, magnesium orthophosphate, magnesium pyrophosphate, and magnesium silicate.
- the deodorant active in the composition may also comprise an organic deodorant active such as triclosan, deousnate, or citricidal, to name a few.
- the amount of any additional deodorant active in the composition according to the invention is typically from 0-20%, preferably 1-15% by weight of the composition.
- the cosmetic vehicle used in compositions according to the invention may include any commonly used cosmetic vehicle material, in addition to the water and short chain monohydric alcohol found in the composition, and may include polyhydric alcohols, and volatile and non-volatile silicones, and conveniently forms the balance of the composition.
- the product form is a propellant driven aerosol
- the composition comprises in addition to the acyl lactylate and other essential components a propellant, which is preferably dimethyl ether.
- a propellant which is preferably dimethyl ether.
- the propellant is present in such propellant driven aerosol compositions at a level of 20 to 80%, more preferably 40 to 60% by weight of the composition.
- suitable propellants include propane, butane, isobutane, carbon dioxide, and nitrous oxide.
- compositions according to the invention may also comprise other components typically found in such compositions, including;
- linear or cyclic volatile silicones including polydimethyl siloxanes such as Dow Corning 344 Fluid and Dow Corning 345 Fluid, and volatile hexamethyldisiloxane such as Dow Corning 200 Fluid,
- non-volatile silicones including polydimethylsiloxane such as Dow Corning Fluids.
- thickeners such as clays, for example Bentone 38, and silicas, for example Aerosil 200,
- skin feel improvers such as talc and finely divided polyethylene, for example Acumist B18
- cosmetically acceptable vehicles such as anhydrous ethanol and other emollients
- gelling agents such as stearyl alcohol or waxes, such as castor wax
- the deodorant composition may additionally comprise antiperspirant active levels of metal salts, such as aluminium and/or zirconium salts. Such active levels are typically 4 to 30% by weight of the composition.
- composition according to the invention can also take the form of liquid or ⁇ id products, each of which is suited to or adapted for topical application to the human skin.
- On convenient form of the product is as a solid stick, usually contained in a suitable holder to enable it to be applied to the area of the skin, particularly the underarm, where it is required.
- a further form of the composition of the invention is a lotion suitable for dispensing from a roll-on dispenser fitted with a ball valve, to enable the product to be rolled onto the skin in a conventional fashion.
- composition of the invention is as a liquid composition suitable for dispensing with a finger operated pump spray or hand operated squeeze spray, to deliver to the skin a finely divided liquid spray, without the use of propellant gases.
- the following propellant driven composition was prepared:
- composition was found to provide good deodorant efficacy and skin moisturization.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9407564A BR9407564A (en) | 1993-08-26 | 1994-08-16 | Deodorant composition |
AU76539/94A AU7653994A (en) | 1993-08-26 | 1994-08-16 | Deodorant composition |
EP94926847A EP0714282A1 (en) | 1993-08-26 | 1994-08-16 | Deodorant composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939317799A GB9317799D0 (en) | 1993-08-26 | 1993-08-26 | Deodorant composition |
GB9317799.6 | 1993-08-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995005799A1 true WO1995005799A1 (en) | 1995-03-02 |
Family
ID=10741097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1994/002745 WO1995005799A1 (en) | 1993-08-26 | 1994-08-16 | Deodorant composition |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0714282A1 (en) |
AU (1) | AU7653994A (en) |
BR (1) | BR9407564A (en) |
GB (1) | GB9317799D0 (en) |
WO (1) | WO1995005799A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3472940A (en) * | 1965-03-25 | 1969-10-14 | Patterson Co C | Stable gelled alcohol compositions containing sodium acyl lactylates |
EP0452968A2 (en) * | 1990-04-20 | 1991-10-23 | Somerville Technology Group, Inc. | Surface modified aluminum and aluminum-zirconium salts |
EP0572271A2 (en) * | 1992-05-29 | 1993-12-01 | Unilever Plc | Acyl lactylates as antimicrobial actives |
EP0573253A2 (en) * | 1992-06-03 | 1993-12-08 | Unilever Plc | Topical anti-bacterial composition |
US5274152A (en) * | 1992-11-27 | 1993-12-28 | Somerville Technology Group, Inc. | Method of preparation of sodium aluminum lactate |
-
1993
- 1993-08-26 GB GB939317799A patent/GB9317799D0/en active Pending
-
1994
- 1994-08-16 BR BR9407564A patent/BR9407564A/en not_active Application Discontinuation
- 1994-08-16 WO PCT/EP1994/002745 patent/WO1995005799A1/en not_active Application Discontinuation
- 1994-08-16 AU AU76539/94A patent/AU7653994A/en not_active Abandoned
- 1994-08-16 EP EP94926847A patent/EP0714282A1/en not_active Ceased
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3472940A (en) * | 1965-03-25 | 1969-10-14 | Patterson Co C | Stable gelled alcohol compositions containing sodium acyl lactylates |
EP0452968A2 (en) * | 1990-04-20 | 1991-10-23 | Somerville Technology Group, Inc. | Surface modified aluminum and aluminum-zirconium salts |
EP0572271A2 (en) * | 1992-05-29 | 1993-12-01 | Unilever Plc | Acyl lactylates as antimicrobial actives |
EP0573253A2 (en) * | 1992-06-03 | 1993-12-08 | Unilever Plc | Topical anti-bacterial composition |
US5274152A (en) * | 1992-11-27 | 1993-12-28 | Somerville Technology Group, Inc. | Method of preparation of sodium aluminum lactate |
Non-Patent Citations (2)
Title |
---|
CHEMICAL ABSTRACTS, vol. 98, no. 26, June 1983, Columbus, Ohio, US; abstract no. 221624g * |
PANDEY ET AL.: "antibacterial properties of soap containing some fatty acid esters", INTERN. JOURN. OF COSMETIC SCIENCE, vol. 7, no. 1, February 1985 (1985-02-01), OXFORD GB, pages 9 - 14 * |
Also Published As
Publication number | Publication date |
---|---|
AU7653994A (en) | 1995-03-21 |
BR9407564A (en) | 1996-12-31 |
EP0714282A1 (en) | 1996-06-05 |
GB9317799D0 (en) | 1993-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1909916B1 (en) | Anhydrous spray compositions containing a particulate antiperspirant active and a moisturising agent | |
EP0966258B2 (en) | Antiperspirant or deodorant composition | |
US4906454A (en) | Deodorant compositions containing specific piroctone salts and perfumes | |
US6221345B1 (en) | Cosmetic composition | |
EP2189149B1 (en) | Antiperspirant compositions | |
EP0957897B1 (en) | Antiperspirant or deodorant compositions | |
EP0471392A2 (en) | Deodorant composition | |
WO2019206764A1 (en) | An antiperspirant composition | |
US5961963A (en) | Antiperspirant composition | |
EP3068366B1 (en) | Use as a deodorant agent of a salified salicylic acid derivative, alone or in a mixture | |
EP0804921A1 (en) | Topical composition | |
EP0714282A1 (en) | Deodorant composition | |
MXPA97002379A (en) | Composition top | |
MXPA99005928A (en) | Antiperspirant or deodorant composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB GE HU JP KE KG KP KR KZ LK LT LU LV MD MG MN MW NL NO NZ PL PT RO RU SD SE SI SK TJ TT UA UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE MW SD AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1994926847 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1994926847 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWR | Wipo information: refused in national office |
Ref document number: 1994926847 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1994926847 Country of ref document: EP |